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The Role of Scleraxis in Fate 
Determination of Mesenchymal 
Stem Cells for Tenocyte 
Differentiation
Yonghui Li1,*, Melissa Ramcharan1,2,*, Zuping Zhou1,*,†, Daniel J. Leong1,2,3,4, 
Takintope Akinbiyi1, Robert J. Majeska2 & Hui B. Sun1,3,4
Mesenchymal stem cells (MSCs) are pluripotent cells that primarily differentiate into osteocytes, 
chondrocytes, and adipocytes. Recent studies indicate that MSCs can also be induced to generate 
tenocyte-like cells; moreover, MSCs have been suggested to have great therapeutic potential for 
tendon pathologies. Yet the precise molecular cascades governing tenogenic differentiation of MSCs 
remain unclear. We demonstrate scleraxis, a transcription factor critically involved in embryonic 
tendon development and formation, plays a pivotal role in the fate determination of MSC towards 
tenocyte differentiation. Using murine C3H10T1/2 pluripotent stem cells as a model system, we 
show scleraxis is extensively expressed in the early phase of bone morphogenetic protein (BMP)-12-
triggered tenocytic differentiation. Once induced, scleraxis directly transactivates tendon lineage-
related genes such as tenomodulin and suppresses osteogenic, chondrogenic, and adipogenic 
capabilities, thus committing C3H10T1/2 cells to differentiate into the specific tenocyte-like lineage, 
while eliminating plasticity for other lineages. We also reveal that mechanical loading-mediated 
tenocytic differentiation follows a similar pathway and that BMP-12 and cyclic uniaxial strain act in 
an additive fashion to augment the maximal response by activating signal transducer Smad8. These 
results provide critical insights into the determination of multipotent stem cells to the tenocyte 
lineage induced by both chemical and physical signals.
Mesenchymal stem cells (MSCs) can give rise to mesenchymal lineages such as osteocytes, chondrocytes, 
and adipocytes, and potentially transdifferentiate into non-mesenchymal cell types such as pancreatic cells 
and cardiomyocytes1–4. MSCs are considered the ideal source of cellular therapeutic agents for tendon 
repair5–8. Although increasing studies show that MSCs can be induced to differentiate into tenocytes5,9,10, 
the potential regulators that govern MSC fate for tenocyte differentiation in tendon neoformation and 
regeneration have not yet been defined. A number of growth factors, particularly members of the bone 
morphogenetic proteins (BMP) family, have been shown to promote tenocytic differentiation from the 
multipotent MSCs9,11,12. Of the more than 20 BMP members13, BMP-12 appears to be the most potent 
tendon inducers identified thus far. BMP-12 gene transfer augments the repair of lacerated tendon9,14 and 
improves Achilles tendon healing15. In vitro, bone marrow MSCs transfected or stimulated with BMP-12 
exhibit efficient generation of tenocyte-like cells6,16. In addition to chemical factors, stimulatory effects of 
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mechanical loading on the tenocytic differentiation have also been described17–19. Despite these efforts, 
however, the molecular mechanisms responsible for the directed differentiation of MSCs into tenocytes 
are not well understood.
During embryogenesis, many transcriptional factors such as Six1 and Six2, EphA4, Eya1 and Eya2, 
follistatin, tenascin, mohawk, and scleraxis are recognized to regulate tendon development and for-
mation20–22. Among them, scleraxis a class II basic helix-loop-helix (bHLH) transcription factor, has 
received particular attention23. Scleraxis (Scx) is expressed in both stem cells and differentiated cells of 
tendons. At E10.5 endogenous Scx can be readily detected in the developing limb buds and in a somatic 
compartment known as syndetome at the dorsolateral edge of the sclerotome24–26, and its expression is 
continued throughout later stages of tendon formation24. Conditional knockout of the Scx gene in mice 
causes a failure in the condensation of tendon stem cells and severe defects in tendon differentiation, 
and consequently a dramatic loss of tendons that are particularly responsible for transmitting muscu-
loskeletal force in the limbs, tail and trunk27. These studies highlight an essential role of Scx in tendon 
development, and suggest that Scx may be critically involved in fate determination of adult MSCs to 
differentiate into tenocytes.
Here we showed that Scx is a key regulator of MSC differentiation into the tenocyte lineage as 
evidenced by its critical involvement both in the activation of downstream genes and suppression of 
non-tenogenic pathways in C3H10T1/2 cells. Our study provides evidence suggesting that the tenocytic 
differentiation process of adult MSCs may recapture the molecular cascades operative in embryonic 
tendon formation.
Results
Scleraxis is induced by BMP-12 in C3H10T1/2 cells. To investigate the involvement of Scx in the 
tenogenic differentiation of MSCs, we first determined whether BMP-12 would induce Scx in C3H10T1/2 
stem cells. As assessed by RT-qPCR, BMP-12 treatment led to strong expression of Scx and Tenomodulin 
(Tnmd), a marker related to later stage tendon formation28. The induction of both genes were dependent 
on the dose of BMP-12; increases in expression of Scx and Tnmd were detectable at 2.5 ng/ml and max-
imal (2.5 ~ 3-fold over untreated controls) at 10–25 ng/ml (Fig. 1A). Simultaneously, BMP-12 downregu-
lated the expression of neucleosteimin (Nst), a pan-stem cell marker (Fig. 1B). Tnmd is subject to positive 
regulation by Scx in a tendon cell lineage-dependent manner28. Consistent with this behavior, induction 
of Tnmd lagged behind induction of Scx following BMP-12 treatment, as evidenced at the mRNA level 
by RT-qPCR (Fig. 1C) and at the protein level by immunostaining (Fig. 1D).
Scleraxis is required for tenomodulin expression in C3H10T1/2 cells. Based on the sequential 
expression of Scx and Tnmd pattern and previous findings that Scx stimulates Tnmd expression28, we 
next determined whether Tnmd expression in C3H10T1/2 cells could be directly regulated by Scx by 
examining Tnmd expression under conditions of Scx gain- and loss-of-function. In transient transfec-
tion assays, C3H10T1/2 cells overexpressing Scx showed significantly upregulated Tnmd compared to 
untransfected and empty vector-transfected cells (Fig. 2A), providing evidence that simply increasing 
the level of Scx can mimic the inductive effect of BMP-12. On the other hand, when Scx expres-
sion was suppressed by transfection with Scx siRNA, the BMP-12-dependent upregulation of both 
Scx and Tnmd seen in untransfected and scrambled siRNA-transfected cells was abolished (Fig.  2B). 
Furthermore, while transfection with Tnmd siRNA blocked BMP-12-induced Tnmd expression, it had 
no effect on expression of Scx (Fig. 2B). Similar results were also obtained at protein levels by Western 
blotting (Fig. 2C).
Scleraxis directly transactivates tenomodulin in C3H10T1/2 cells. Scx modulates the expression 
of target genes by binding to a consensus sequence (CANNTG) called E-box within promoters29. To 
test whether Scx might directly transactivate the transcription of Tnmd via this mechanism, we car-
ried out electrophoretic mobility shift assays (EMSA) using olgionucleotide probes containing a putative 
E-box and sequences from the Tnmd promoter flanking both sides of the E-box. As shown in Fig. 3A, 
a protein-DNA complex was detected only when probes were incubated with nuclear extracts prepared 
from cells expressing high levels of Scx due to transfection (Fig.  3A, lane 3) or BMP-12-treatment 
(Fig. 3A, lane 4). The shifted bands became undetectable in the presence of excess unlabeled wild-type 
(Fig. 3A, lane 6, 7) or mutant probes (Fig. 3A, lane 9, 10). To identify specific E-box sites in the Tnmd 
promoter that interact with Scx, we further conducted chromatin immunoprecipitation (ChIP) assays. 
Of the five putative E-boxes found within the − 3000 bp region of the Tnmd promoter, E-boxes 1 to 4, 
but not E-box 5, demonstrated functional interactions with Scx (Fig. 3B).
Scleraxis promotes tenocytic differentiation by suppressing non-tenogenic potentials of 
C3H10T1/2 cells. Loss of Nst expression in C3H10T1/2 cells stimulated by BMP-12 suggests that 
tenocyte differentiation may be associated with loss of stem cell features, which are likely reflected by 
a decline in the capacity to differentiate along alternative pathways. Therefore, we next determined 
whether Scx was involved in the suppression of non-tenogenic potential. RT-qPCR analysis showed 
in C3H10T1/2 cells plated at colony-forming densities and treated with varying concentrations of 
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BMP-12, Scx-expressing colonies increased in a BMP-12 dose-dependent manner (Supplementary Fig. 
S1), although not all of them expressed Scx.
We further tested whether Scx-positive (Scx+) and Scx-negative (Scx−) colonies differ in their dif-
ferentiation potentials using a single CFU-F re-plating assay (SCRA) (Fig.  4A). When cells from indi-
vidual Scx-positive (Scx+) and Scx-negative (Scx−) colonies were re-plated in lineage-specific induction 
media, cytochemical staining for lineage specific markers revealed that the osteogenic, chondrogenic 
and adipogenic differentiation were largely suppressed in Scx+ colony-derived cells, but maintained in 
cells from Scx− colonies (Fig. 4B,C). These results were further confirmed by assessing mRNA levels of 
lineage-specific genes (Fig. 4D).
To test a direct role for Scx and/or Tnmd in suppressing non-tenocytic activities, the loss of func-
tion of both genes were examined. As shown in Fig.  5, marked increases in the expression of osteo-, 
chondro-, and adipose-specific genes were detected in Scx siRNA transfected cells in the presence of 
induction media. The expression of these genes was increased in untransfected and scrambled siRNA 
transfected cells that received BMP-12 treatment to induce Scx prior to lineage induction, or in those 
without induction. These data show Scx is a negative regulator of the osteogenic, chondrogenic, and adi-
pogenic pathways. Notably, silencing of Tnmd in the presence of high levels of Scx did not fully suppress 
non-tenogenic gene expression, especially chondrocyte- and adipocyte markers, showing that Tnmd may 
also participate in suppression of non-tenocytic potentials.
Figure 1. Induction of scleraxis and tenomodulin by BMP-12 in C3H10T1/2 stem cells. (A) Upregulation 
of Scx and Tnmd. (B) Downregulation of Nst Expression. Cells were left untreated or treated with different 
concentrations of BMP-12 for 24 hours. mRNA levels were determined by RT-qPCR. Data are expressed 
as mean ± S.D. (n = 6). *p < 0.05. (C,D) Time course of Scx and Tnmd expression. Cells were treated with 
10 ng/ml of BMP-12 for different lengths of time. mRNA (C) and protein (D) levels of gene expression 
were determined by RT-qPCR and immunostaining, respectively. Data in (C) are expressed as mean ± S.D. 
(n = 3).
www.nature.com/scientificreports/
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Combining cyclic loading and BMP-12 enhances expression of Scx and formation of 
tenocyte-like cells. Mechanical stress has been shown to influence tenocytic differentiation from 
MSCs in vitro19,30 and from tendon stem and progenitor cells in vivo18,31–34. Therefore, we further tested 
whether mechanical loading also modulates tenocyte differentiation in C3H10T1/2, and whether such a 
physical stimulus can act synergistically or additively with BMP-12. We first assessed the effects of cyclic 
uniaxial strain loading on Scx expression. Compared to non-loaded controls, significant increases in 
Scx expression were observed in all loading-stimulated groups of cells with maximal expression in cells 
loaded at 5% strain (Supplementary Fig. S2A) at 0.5 Hz (Supplementary Fig. S2B).
We next examined the combined effects of BMP-12 and stretch loading. Consistent with experiments 
described above, both mechanical loading and BMP-12 treatment resulted in significant increases in Scx 
mRNA expression though the latter provoked a more pronounced response. When the two stimuli were 
applied simultaneously, however, the increases in gene expression appeared to be additive (Fig.  6A). 
Toluidine blue staining revealed that cells treated with a combination of mechanical loading plus BMP-
12- appeared to resemble more closely mature tenocytes (Fig. 6B) as evidenced by a greater elongation 
(Fig. 6C) and cell alignment (Fig. 6D). The data show that physical and biochemical signals can interact 
cooperatively to facilitate differentiation into tenocytic cells.
Smad8 is an upstream signaling molecule of Scx required to mediate the teno-inductive 
response of cyclic loading and BMP-12. Members of the receptor-regulated Smads (R-Smads) sub-
class, Smad1/5/8, are the major signaling transducers for BMPs35. We monitored the phosphorylation 
of these proteins in cells under different treatment conditions. While BMP-12 and stretch loading each 
induced extensive phosphorylation of Smad 1/5/8, significantly increased R-Smad phosphorylation was 
observed over the two time-points in cells that had received both stimuli (Fig. 7A). The data demonstrate 
that BMP-12 and mechanical loading signaling may interact at the R-Smad site, thus leading to augmen-
tation of tenocytic differentiation.
Figure 2. Scleraxis-dependent expression of tenomodulin in C3H10T1/2 cells. (A) Overexpression 
of Scx upregulated Tnmd. Cells were left untransfected or transiently transfected with empty vectors or 
vectors containing Scx or Tnmd cDNA. mRNA levels were determined by RT-qPCR. Data are expressed as 
mean ± S.D. (n = 3). *p < 0.01. (B,C) Knockdown of Scx blocked BMP-12-induced Tnmd. C3H10T1/2 cells 
untransfected or transfected with scramble siRNA, or Scx siRNA, or Tnmd siRNA were left untreated or 
stimulated with BMP-12, and mRNA and protein levels of gene expression were determined by RT-qPCR 
and Western blot, respectively. Data in (B) are expressed as mean ± S.D. (n = 6). *p < 0.05.
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To pinpoint the Smad molecule specifically involved in the mechanical loading and BMP-12 induc-
tion of Scx, we assessed the effects of Smad1, Smad5 or Smad8 suppression. Phosphorylation of Smad 
1/5/8 mediated by BMP-12, loading, or both, was almost entirely repressed upon Smad8 knockdown by 
siRNAs (Fig. 7B), concurrent with absence of Scx induction associated with the treatments (Fig. 7C). In 
contrast, Smad1 or Smad5 knockdown (Fig. 7D) had minimal impact on the overall phosphorylation of 
Smad 1/5/8 (Fig. 7E).
Discussion
Stem cell-based approaches are considered to have a great potential to improve healing of soft tissue 
injuries, which account for nearly half of the 33 million musculoskeletal injuries that occur in the United 
States each year36. The effective use of MSCs relies on a better understanding of the signaling pathways 
that control their differentiation into tenocytes. In the present study, we have demonstrated for the first 
time that scleraxis, a class B bHLH transcription factor, is critical in determining the fate of C3H10T1/2 
stem cells to commit to a tenocyte lineage.
Figure 3. Transactivation of tenomodulin by scleraxis in C3H10T1/2 cells. (A) Binding of Scx to Tnmd 
E-boxes assessed by electrophoretic mobility shift assays (EMSA) Olgionucleotide probes corresponding 
to a specific E-box consensus sequence were incubated with nuclear extracts from C3H10T1/2 cells with 
either Scx overexpression and/or BMP-12 treatment or left untreated (control). (B) Binding of Scx to Tnmd 
E-boxes assessed by chromatin immunoprecipitation (ChIP) assays. Cross-linked chromatins were prepared 
by immuneprecipitated cellular lysates using anti-scleraxis antibodies and purified DNA was used to PCR 
amplify the biding regions of Tnmd promoter. The binding of Scx to all tested Tnmd E-boxes except 5 was 
detected in BMP-12-treated cells. Upper panel, distribution and localization of E-boxes in Tnmd promoter.
www.nature.com/scientificreports/
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We showed that the induction of Scx was a key early event occurring in the BMP-12-mediated ten-
ocytic differentiation of C3H10T1/2 cells and required to regulate the expression of downstream gene 
Tnmd, a well characterized marker related to a late stage of tenocyte differentiation28. This conclusion was 
supported by several lines of evidence. First, treatment with recombinant BMP-12 proteins led to sequen-
tial expression of Scx and Tnmd in C3H10T1/2 stem cells. Second, overexpression of Scx in C3H10T1/2 
cells simulated the effect of BMP-12 on the upregulation of Tnmd whereas knockdown of Scx abolished 
BMP-12 induced Tnmd, indicating that the advent and presence of Scx is substantive to the ensuing 
expression of Tnmd. Third, altering the expression levels of Tnmd had minimal impact on Scx induction 
as demonstrated in comparable experiments on Tnmd gain- and loss-of-function. Finally, Scx directly 
transactivated Tnmd, a process entailing the recruitment and binding of Scx to the multiple selective 
E-boxes within the promoter region of Tnmd. Although we have not examined other later markers along 
the teno-differentiation such as type I collagen genes and aggrecan, Scx may also be poised to modulate 
the expression of these genes as well29,37,38. Our previous study demonstrated that BMP-12 treatment of rat 
adult MSCs derived from bone marrow (BM-MSCs) induces these adult stem cells undergoing tenocyte 
differentiation, as remarked by expression of not only Scx and Tnmd, but also other late teno-phenotypic 
markers collagen I and tenascin C9. The BMP-12 treated MSCs showed ability in augmenting tendon-like 
tissue formation and defect repair in vivo. Together, these studies suggest induction of Scx is a key early 
Figure 4. Scleraxis induction is associated with loss of non-tenogenic potential of C3H10T1/2 cells. 
(A) Schematic procedures of single CFU-F replating assay (SCRA). (B) Cytochemical staining of osteo-(left 
panel), chondro-(middle panel), and adipo-(right panel) differentiation. (C) Immunohistochemical staining 
of lineage-specific markers. Data shown in B and C are representatives of three experiments. (D) mRNA 
expression of lineage-specific marker genes determined by RT-qPCR. Data are expressed as mean ± S.D. 
(n = 6). *p < 0.01.
www.nature.com/scientificreports/
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event in BMP-12-mediated tenocyte differentiation in both embryonic-derived (i.e. C3H10T1/2) and 
adult (i.e. BM-MSCs) MSCs.
In addition to its indispensable role in the control of downstream genes within the tenogenic path-
way, Scx might also be directly responsible for the suppression of non-tenocytic differentiation poten-
tials of C3H10T1/2 cells. Utilizing a sophisticated approach combining single colony-forming assay and 
RT-qPCR, we were first able to identify and successfully separate two types of colonies: Scx+ and Scx- 
colonies, and found that while the osteogenic, adipogenic, and chondrogenic capabilities were largely 
abrogated in Scx-positive cells, all of those distinct lineage potentials were, surprisingly, well maintained 
in Scx-negative cells. The inhibitory role of Scx was collaborated by the observation that upon repres-
sion of Scx by siRNA, C3H10T1/2 cells were capable of retaining their multi-lineage potentials even in 
the presence of BMP-12, which was exactly the same as those observed with Scx- cells. In support of 
our data, reports documented that Scx and Sox9, a master transcription factor for chondrogenesis39,40, 
are co-expressed in sclerotome during the early stage of embryonic development, but Scx is markedly 
Figure 5. Scleraxis knockdown preserves multi-potent potentials in C3H10T1/2 cells. Untransfected 
C3H10T1/2 cells or cells transfected with scramble siRNA, or Scx siRNA, or Tnmd siRNA were left 
untreated or treated with BMP-12 for 24 hours and further incubated for designed length of time in the 
absence or presence of lineage induction media. The phenotypes (Scx and Tnmd expression) of respective 
groups of cells and mRNA expression of lineage-specific marker genes were assayed by RT-qPCR. Data are 
expressed as mean ± S.D. (n = 6). *p < 0.05.
www.nature.com/scientificreports/
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reduced in the center of Sox9-expresssed sclerotome following development41, underlining a potentially 
suppressive function for Scx in the chondrogenesis.
It should be pointed out, however, that Scx alone appeared to be insufficient to drive MSC differentia-
tion into tenocytes. Scx+ colony-derived cells still expressed osteo-, chondro-, and adipogenic potentials at 
low but detectably greater levels than un-induced controls (Fig. 4D). We observed a similar phenomenon 
in cells where only Tnmd, but not Scx, was silenced with siRNA (Scx+ Tnmd- cells) (Fig. 5). Most likely, 
the Scx+ colonies derived from single colony-forming assays may harbor Scx+ Tnmd− and Scx+ Tnmd+ 
sub-fractions, and the former are responsible for the low level of differentiation along non-tenogenic 
pathways. Given these considerations, we propose that the phenotypic plasticity of C3H10T1/2 cells 
becomes progressively limited during tenocytic differentiation, and that these changes occur in stages 
that are functionally determined by the sequential expression of Scx and Tnmd. In the earlier stage, Scx 
appears to play a central role both in triggering the expression of tenocyte-associated genes (Tnmd and 
possibly type I collagen, tenascin-C, type XIV collagen), as well as in suppressing non-tenogenic capacity. 
At the later (Scx+/Tnmd+) stage, cells become fully committed to the tenocyte phenotype and completely 
lose their capacity to differentiate into non-tenocyte lineages, at least under the conditions we examined.
The critical role of Scx in tenocyte differentiation of C3H10T1/2 cells was not limited to induction 
by BMP-12, but was also required for mechanical load-triggered tenocytic differentiation. Moreover, 
combination of the biochemical and mechanical stimuli led to marked augmentation of the differentia-
tion response incurred by either stimulus alone as evidenced by increased Scx expression and enhanced 
formation of tenocyte-like cells. Furthermore, we found that both BMP-12 and stretch loading induced 
extensive phosphorylation of Smad8 but differed in the time course of this biochemical process. The 
mediation of both BMP-12 and stretch loading responses by the Smad system provides a molecular basis 
to explain not only the crosstalk between these stimuli in controlling tenocyte differentiation, but also the 
downregulation of non-tenogenic potency by Scx since Smad8 has been shown to promote neotendon 
formation by inhibiting the osteogenic pathway induced by BMP-242. Together, this study suggests that 
Smad8 is a key signaling molecule whose activation is required to mediate Scx expression and ensuing 
tenocytic differentiation of C3H10T1/2 cells in response to BMP-12 and stretch loading.
In summary, we have identified scleraxis as a central regulator responsible for the fate determination 
of C3H10T1/2 cells to differentiate into tenocytes and suppress alternate pathways for differentiating into 
other lineages. Both actions are induced by mechanical as well as chemical stimuli that are mediated 
intracellularly by phosphorylation of Smad8 and act in an additive fashion. These findings offer novel 
insights into the molecular cascades underlying tenocyte differentiation from pluripotent stem cells, and 
may contribute to the development of cell-based tissue engineering approaches useful for tendon repair.
Figure 6. Compound effects of BMP-12 and cyclic loading on the tenocytic differentiation of 
C3H10T1/2 stem cells. (A) Induced expression of Scx by BMP-12 and cyclic stretch loading. Cells were 
left untreated or treated with BMP-12 alone, or cyclic loading alone, or BMP-12 plus cyclic loading. After 
incubation, cells were harvested and analyzed for Scx mRNA expression by RT-qPCR. Data are expressed as 
mean ± S.D. (n = 3). *p < 0.05. (B) BMP-12 and stretch loading induced cell morphological changes. Cells 
were treated as in (A) and stained with toluidine blue. (C) Nuclear aspect ratio: width vs length of nucleus; 
(D) Nuclear orientation angle: deviation of nuclear axis from average axis. *p < 0.05. C: Control, B: BMP-12 
only, S: stretch loading only, B + S: BMP-12+stretch loading.
www.nature.com/scientificreports/
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Methods
Cell culture and stimulation. Murine pluripotent mesenchymal stem cells C3H10T1/2 (ATCC 
CCL226)43 were grown as monolayers in DMEM with 10% fetal bovine serum. Twenty-four hours prior 
to BMP-12 treatment or mechanical loading, cells were starved for 12 hours in DMEM supplanted with 
1% FBS. For BMP-12 treatment, cells were treated with indicated concentration of recombinant mouse 
BMP-12 (R&D Systems) or PBS (control) in starving media for an additional 12 hours. For mechanical 
loading, cells were subjected to uniaxial cyclic loading for 1 hour with indicated load levels using a cus-
tom-designed cell-loading device connected to a computer controlled linear stepper motor (Anaheim 
Automation). For combined treatment experiments, cells were treated with BMP-12 for 11 hours and 
then further treated with BMP-12 for one more hour or subjected to uniaxial cyclic loading for 1 hour 
at indicated load levels. Following treatments, cells were maintained for an additional 3 to 7 days and 
collected for analysis of gene expression and morphological changes.
Figure 7. Dependency of Smad8 activation in BMP-12 and cyclic stretch loading signals. (A) Enhanced 
Smad 1/5/8 phosphorylation induced by combined treatment of BMP-12 and cyclic stretch loading. Cells 
under indicated treatment were harvested at 1 hour and 2 hours post-treatment to analyze the levels of 
Smad1/5/8 phosphorylation by Western blot. (B–E) Activation of Smad8 in C3H10T1/2 stem cells in 
response to BMP-12 and stretch loading. Cells were transfected with siRNA against Smad1, Smad5, Smad8, 
or control siRNA, (siScr) followed by treatment of BMP-12 or loading or both, and protein phosphorylation 
analyzed by Western blot. C: Control, B: BMP-12 only, S: stretch loading only, B + S: BMP-12+stretch loading, 
Scr: Scramble of siRNA, siS1: siRNA-Smad1, siS5: siRNA-Smad5, siS8: siRNA-Smad8.
www.nature.com/scientificreports/
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Single CFU-F replating assay (SCRA). To determine the differentiation potential of Scx+ and Scx− 
cells derived BMP-12 treated stem cells, SCRA was performed as previously described (20). Briefly, cells 
were seeded at low density (1 × 103/100 mm culture dish) and cultured for two weeks. Individual colonies 
were collected with EDTA–trypsin. Cell suspensions from each colony were divided into four portions: 
one of them was used to assay Scx expression by RT-qPCR, and the remaining three portions of cells were 
replated in individual wells of a 48-well plate containing either osteogenic, chondrogenic, or adipogenic 
differentiation medium. The osteogenic induction cocktail consisted of growth media supplemented with 
10 nM dexamethasone, 50 μ g/ml ascorbate-phosphate, and 10 mM β -glycerophosphate (Sigma). The adi-
pogenic induction cocktail consisted of growth media supplemented with 0.5 uM hydrocortisone, 100 μ g/
ml isobytulmethylxanthine, and 60 μ M indomethacin (Sigma). For chondrogenic induction, cells were 
grown in a micromass culture. 1 × 106 cells were centrifuged in a polypropylene tube at 150 g for 5 min 
to form a cell pellet. The pellet was suspended in a chondrogenic induction cocktail consisting of growth 
media supplemented with 10 ng/ml TGF-β 3, 50 mg/ml insulin-transferrin-selenium (ITS) + Premix 
(Invitrogen), and 50 ug/mL ascorbate-phosphate. Cells were harvested after two weeks lineage induction 
and assayed for osteo-, chondro-, or adipo-phenotype markers gene expression using RT-qPCR or in 
some cases by immunocytochemical staining.
Immunocytochemical staining (ICC). Cells were fixed in 10% formaldehyde, treated with serum-free 
protein blocking solution (Dako), and then incubated overnight at 4 °C with antibodies against Scx 
(1:150, Abcam, Rabbit polyclonal), Tnmd (1:150, Santa Cruz Biotechnology, Goat Polyclonal), Runx2 
(1:200, Abcam, Rabbit polyclonal), Sox9 (1:200 Santa Cruz Biotechnology, Rabbit polyclonal), PPARγ 2 
(1:200, Abcam, Rabbit polyclonal), or aggrecan (1:200, Abcam, Rabbit polyclonal). Cells were then 
rinsed in PBS. For Scx and Tnmd staining, cells were incubated with anti-rabbit Alexafluor 488 (1:1000, 
Invitrogen) or anti-goat Alexafluor 568 (1:1000, Invitrogen). For the other antibodies, cells were incu-
bated for 30 minutes with anti-rabbit secondary antibody conjugated with horseradish peroxidase (Dako) 
followed by DAB chromagen (Vector Laboratories) for 2 minutes. Negative control sections were pre-
pared using irrelevant isotype matched primary antibodies (Dako).
Cytochemical Staining (CCS). Osteogenic, adipogenic and chondrogenic differentiation were 
assessed by staining with Alizarian Red S (Sigma) for calcium deposition, Oil Red O (Sigma) and 
Safranin-O, respectively44. Imaging was performed using a Zeiss inverted microscope, Axiocam camera 
and Axiovision 4.6 software.
Electrophoretic mobility shift assay (EMSA). Nuclear extracts of C3H10T1/2 cells—either trans-
fected to overexpress Scx, treated with 10 ng/ml BMP-12 or left untreated—were incubated with olgio-
nucleotide probes containing a specific E-box consensus sequence. Probe sequences were 18 bp long and 
contained the 6-mer E-box consensus sequence (CANNTG) flanked by 6-mer sequences on each side of 
the E-box to increase the probe’s specificity. Probes were labeled with [α -32P] dCTP (PerkinElmer Life 
Sciences) for detection. Specific binding was assessed by competition with an excess of the unlabeled, 
wild-type (CANNTG) probes and mutated (CANNTG→ AATTTA) probes.
Chromatin immunoprecipitation (ChIP) assay. C3H10T1/2 cells were treated with 10 ng/ml BMP-
12 to induce Scx expression or left untreated (control). The ChIP assay was performed using a com-
mercial kit (USB Corporation) following the manufacturer’s instructions. Briefly, cells were treated with 
1% formaldehyde to cross-link the scleraxis molecules bound to DNA, and cells were then lysed and 
sonicated. The samples were immuno-purified using Scx antibodies (Abcam). The subsequent samples 
were then heated to reverse DNA-protein cross-links and DNA was recovered by phenol/chloroform 
extraction and resuspended in 10 mM Tris-HCl buffer. Purified DNA was PCR amplified using primer 
sets designed to include individual E-box sequences with the following priemrs: E-box1 (from start 
codon): F, 5-CTGAGTTTGCGATTTCTGAGTT-3; R, 5-CTCGATTCTGTGCCTGTAACC-3. E-box2: 
F, 5-AAGAAAGCAAGCTGGAGGAA-3; R, 5-GAGCATCTGTACCCGGATGT-3. E-box3: F, 5-CGTTT 
CTTCTTCCTTCCTTCC-3; R, 5-ACCTCACCCTTCCCTGTCTT-3. E-box4: F 5-TGTATATTATGGT 
TTCCAATG-3; R, 5-GAAGGAAGGAAGAAGAAACG-3. E-box5: F, 5-TGTGTTTCTCCAGGGGAGTC- 
3; R, 5-CACACACACACTGTGCCAAA-3.
Total RNA isolation, Reverse transcription and quantitative PCR (RT-qPCR).  Total RNA was 
isolated using the RNeasy Mini Kit (Qiagen). Reverse transcription was carried out using oligodT and 
Superscript II (Invitrogen). RT-qPCR was performed with a SYBR Green PCR Master Mix (Applied 
Biosystems) using ABI Prism 7900HT sequence detection system (Applied Biosystems), and normal-
ized with GAPDH and β -actin levels. The housekeeping genes have been confirmed to be not regulated 
by stimuli such as BMP-12. Data were analyzed using the threshold cycle (Ct)-relative quantification 
method. Primer pairs used in this study are listed in Supplementary Table S1.
Overexpression of Scx and Tnmd. Enforced expression of Scx and Tnmd were performed by trans-
fecting C3H10T1/2 cells with vectors containing the coding region of murine Scx or Tnmd, or with no 
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insert using Lipofectamine 2000 reagent (Invitrogen). Cells were then analyzed for Scx and Tnmd mRNA 
expression by RT-qPCR.
siRNA Transfections. siRNA transfections were carried out using Lipofectamine 2000 reagent 
(Invitrogen) according to the manufacturer’s instructions. C3H10T1/2 cells were transfected with either 
Scx-siRNA, Tnmd-siRNA, Smad1-siRNA, Smad5-siRNA, or Smad8-siRNA (Santa Cruz Biotechnologies, 
Inc., Santa Cruz, CA). Cells were then treated with 10 ng/ml BMP-12 for 12 hours prior to harvest for 
RT-qPCR or Western blot.
Western Blot. Cell lysates were prepared using RIPA lysis buffer (Pierce Technologies) and protease 
and phosphatase inhibitor (Thermo Scientific). Proteins were separated in 12% SDS-PAGE gel and trans-
ferred onto a nitrocellulose membrane and blocked with milk protein. Membranes were incubated with 
anti-Scx (1:1000, Rabbit polyclonal, Santa Cruz Biotechnology), anti-Tnmd (1:1000, Rabbit polyclonal, 
Santa Cruz Biotechnology), anti-phospho-Smad 1/5/8 (1:1000, Rabbit polyclonal, Millipore), anti-Smad8 
(1:1000, Rabbit polyclonal, Santa Cruz Biotechnology), or α -Tubulin (1:1000, Rabbit polyclonal, Santa 
Cruz Biotechnology) followed by incubation with anti-rabbit conjugated with horseradish peroxidase 
(Santa Cruz Technologies). Membranes were washed with TBST and immunoreactivity was normalized 
by chemiluminescence using ECL Plus Detection system (Amersham Biosciences).
Statistical analysis. The data were expressed as mean ± S.D. Statistical comparisons between two 
groups were performed using Student’s t-test or one-way ANOVA with Tukey post-hoc test (for RT-qPCR 
results). p < 0.05 was considered statistically significant.
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